BioSpace News Archive

Suicide is the tenth leading cause of death in the United States, and it is the ninth leading cause of death in South Dakota.

Sculpture to protest the Purdue owned drug maker for their production of opioids.

Frequency Therapeutics, a clinical-stage biotechnology company creating a new class of drugs based on small molecule stimulation of dormant stem cells within the body which we refer to as Progenitor Cell Activation (PCA), today announced that the Company will present a podium presentation at the upcoming 42nd Annual Mid-Winter Meeting of the Association for Research in Otolaryngology (ARO) in Baltimore, MD, taking place February 9-13, 2019.

The goal of the collaboration with NCI is to successfully file an IND for ATI-1013

- Liver biopsy analysis detected targeted integration of IDS transgene, providing preliminary molecular evidence of in vivo genome editing in humans

UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, has introduced oral health strategies to confront the opioid epidemic, building on a companywide approach to address the epidemic from all angles

The nation’s leading scalp micropigmentation professionals at Hairline Ink are pleased to announce the opening of their newest location in San Antonio at 6454 N New Braunfels Ave. #24.

Kerecis, the company pioneering the use of fish skin in tissue regeneration, today received a notice from Swiss healthcare authorities that the company’s lead product, Kerecis Omega3 Wound, will be reimbursed in Switzerland.

The Honourable Ginette Petitpas Taylor, Minister of Health, will be at Université de Moncton tomorrow, on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development, to celebrate an infrastructure project supported through the Post-Secondary Institutions Strategic Investment Fund.

Savoy, a leading benefits consulting firm and general agency, announces that Scott C. Overholt has joined the company in the role of Vice President, Consumer and Senior Markets.